Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific GALNT8 GALNAC-T8 ENSG00000130035 Polypeptide N-acetylgalactosaminyltransferase 8 12 4720341-4851927 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012638, HPA014418, HPA073461 Uncertain Uncertain Vesicles Tissue enhanced 0 rectum: 25.9 colon: 12.1 KCNA1 AEMK, HUK1, Kv1.1, MBK1, RBK1 ENSG00000111262 Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) 12 4909905-4931361 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022365 Uncertain Tissue enriched 19 cerebral cortex: 6.9 thyroid gland: 0.3 KCNA10 Kv1.8 ENSG00000143105 Potassium voltage-gated channel, shaker-related subfamily, member 10 1 110517251-110518838 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA015061, CAB022564 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Not detected testis: 0.4 KCNA2 HK4, Kv1.2 ENSG00000177301 Potassium voltage-gated channel, shaker-related subfamily, member 2 1 110593580-110631474 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001976 Uncertain Group enriched 5 cerebral cortex: 8.5;thyroid gland: 2.2 tonsil: 1.0 KCNA3 HLK3, HPCN3, Kv1.3, MK3 ENSG00000177272 Potassium voltage-gated channel, shaker-related subfamily, member 3 1 110672465-110675033 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016625 Uncertain Mixed lymph node: 6.7 KCNA4 HK1, HPCN2, KCNA4L, Kv1.4 ENSG00000182255 Potassium voltage-gated channel, shaker-related subfamily, member 4 11 30009741-30017023 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001977, HPA016422 Uncertain Tissue enhanced 0 adrenal gland: 5.1;cerebral cortex: 2.2 heart muscle: 1.1 KCNA5 HK2, HPCN1, Kv1.5 ENSG00000130037 Potassium voltage-gated channel, shaker-related subfamily, member 5 12 5043989-5046788 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021516, CAB022562 Supportive Group enriched 5 esophagus: 4.0;heart muscle: 12.6 adipose tissue: 1.5 KCNA6 HBK2, Kv1.6, PPP1R96 ENSG00000151079 Potassium voltage-gated channel, shaker-related subfamily, member 6 12 4809176-4813412 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB011539, HPA014418 Uncertain Not detected heart muscle: 0.1 KCNB1 Kv2.1 ENSG00000158445 Potassium voltage-gated channel, Shab-related subfamily, member 1 20 49363877-49482647 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001979, HPA042434 Supportive Tissue enhanced 0 adipose tissue: 7.2;cerebral cortex: 10.8 fallopian tube: 4.7 KCNC1 Kv3.1 ENSG00000129159 Potassium voltage-gated channel, Shaw-related subfamily, member 1 11 17734812-17783055 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047634 Supportive Tissue enriched 6 cerebral cortex: 7.6 testis: 1.1 KCNC2 Kv3.2 ENSG00000166006 Potassium voltage-gated channel, Shaw-related subfamily, member 2 12 75040077-75209868 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019664, CAB022571 Uncertain Supportive Cytoplasm, Plasma membrane Tissue enriched 10 cerebral cortex: 19.2 prostate: 1.9 KCNC3 Kv3.3, SCA13 ENSG00000131398 Potassium voltage-gated channel, Shaw-related subfamily, member 3 19 50311937-50333515 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018041 Uncertain Mixed fallopian tube: 9.5 KCNC4 C1orf30, HKSHIIIC, Kv3.4 ENSG00000116396 Potassium voltage-gated channel, Shaw-related subfamily, member 4 1 110211343-110283100 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014740 Uncertain Uncertain Nucleoli, Cytoplasm Mixed cerebral cortex: 3.5 KCND1 Kv4.1 ENSG00000102057 Potassium voltage-gated channel, Shal-related subfamily, member 1 X 48961378-48971569 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA000524, HPA001066 Uncertain Uncertain Nucleus Mixed gallbladder: 2.3 KCND2 KIAA1044, Kv4.2, RK5 ENSG00000184408 Potassium voltage-gated channel, Shal-related subfamily, member 2 7 120273668-120750331 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029068 Uncertain Tissue enhanced 0 cerebral cortex: 11.0 gallbladder: 3.2 KCND3 KSHIVB, Kv4.3, SCA19, SCA22 ENSG00000171385 Potassium voltage-gated channel, Shal-related subfamily, member 3 1 111770662-111989155 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029452 Uncertain Mixed cerebral cortex: 13.7 KCNF1 IK8, KCNF, kH1, Kv5.1 ENSG00000162975 Potassium voltage-gated channel, subfamily F, member 1 2 10911937-10914225 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB004678, HPA014738 Supportive Uncertain Golgi apparatus Tissue enriched 26 cerebral cortex: 17.0 endometrium: 0.6 KCNG1 K13, KCNG, kH2, Kv6.1 ENSG00000026559 Potassium voltage-gated channel, subfamily G, member 1 20 51003656-51023129 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039530, HPA040024 Uncertain Supportive Vesicles Tissue enhanced 0 endometrium: 9.4 placenta: 7.1 KCNG2 KCNF2, Kv6.2 ENSG00000178342 Potassium voltage-gated channel, subfamily G, member 2 18 79863668-79900184 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA048628 Uncertain Not detected cerebral cortex: 0.1 KCNG4 Kv6.4 ENSG00000168418 Potassium voltage-gated channel, subfamily G, member 4 16 84218667-84239750 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level No evidence Evidence at transcript level HPA039161 Uncertain Not detected adrenal gland: 0.2 KCNH1 eag, eag1, h-eag, Kv10.1 ENSG00000143473 Potassium voltage-gated channel, subfamily H (eag-related), member 1 1 210678315-211134115 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019445 Supportive Tissue enriched 10 cerebral cortex: 5.6 adrenal gland: 0.5 KCNH2 erg1, HERG, Kv11.1, LQT2 ENSG00000055118 Potassium voltage-gated channel, subfamily H (eag-related), member 2 7 150944961-150978315 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006838, HPA040783, HPA056584 Uncertain Tissue enhanced 0 bone marrow: 21.1;testis: 18.8 heart muscle: 7.1 KCNH3 BEC1, elk2, Kv12.2 ENSG00000135519 Potassium voltage-gated channel, subfamily H (eag-related), member 3 12 49539157-49558308 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051088 Uncertain Group enriched 6 cerebral cortex: 10.8;fallopian tube: 4.4 testis: 1.3 KCNH5 eag2, H-EAG2, Kv10.2 ENSG00000140015 Potassium voltage-gated channel, subfamily H (eag-related), member 5 14 62699454-63102037 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA030487 Uncertain Uncertain Cytoskeleton (Microtubules), Microtubule organizing center Tissue enhanced 0 adrenal gland: 1.0;cerebral cortex: 1.9 testis: 0.3 KCNH6 erg2, HERG2, Kv11.2 ENSG00000173826 Potassium voltage-gated channel, subfamily H (eag-related), member 6 17 63523334-63548977 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level CAB022674 Uncertain Tissue enhanced 0 kidney: 5.1;prostate: 2.5;small intestine: 3.4 duodenum: 1.5 KCNH7 erg3, HERG3, Kv11.3 ENSG00000184611 Potassium voltage-gated channel, subfamily H (eag-related), member 7 2 162371407-162838730 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018039 Uncertain Tissue enriched 6 cerebral cortex: 2.4 stomach: 0.3 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium voltage-gated channel, KQT-like subfamily, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supportive Tissue enhanced 0 adrenal gland: 84.9;thyroid gland: 79.6 stomach: 42.4 KCNQ2 BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2 ENSG00000075043 Potassium voltage-gated channel, KQT-like subfamily, member 2 20 63406039-63472638 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016642, HPA057112 Uncertain Uncertain Endoplasmic reticulum Group enriched 13 adrenal gland: 5.5;cerebral cortex: 21.5;testis: 10.2 prostate: 0.9 KCNQ4 DFNA2, Kv7.4 ENSG00000117013 Potassium voltage-gated channel, KQT-like subfamily, member 4 1 40784012-40840452 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018305 Uncertain Mixed smooth muscle: 1.3 KCNQ5 Kv7.5 ENSG00000185760 Potassium voltage-gated channel, KQT-like subfamily, member 5 6 72621792-73198851 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA016655 Uncertain Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 11.4;thyroid gland: 7.9 skeletal muscle: 5.6 KCNS2 Kv9.2 ENSG00000156486 Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 8 98427022-98432848 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051417 Uncertain Tissue enhanced 0 cerebral cortex: 3.7 urinary bladder: 0.8 KCNS3 Kv9.3 ENSG00000170745 Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 2 17877847-18361616 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA014864 Uncertain Uncertain Cytoplasm, Plasma membrane, Golgi apparatus Tissue enhanced 0 lung: 22.4;skeletal muscle: 22.2 placenta: 9.8 KCNV2 Kv8.2 ENSG00000168263 Potassium channel, subfamily V, member 2 9 2717502-2730037 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031131 Uncertain Tissue enriched 32 testis: 3.1 adipose tissue: 0.0